[关键词]
[摘要]
视网膜静脉阻塞(retinal vein occlusion，RVO)是最常见的视网膜血管病变，临床上视力损害甚至失明的主要原因是黄斑水肿和视网膜新生血管。药物治疗是目前治疗RVO公认的有效安全的方法，其中最主要的药物治疗包括皮质类固醇激素类药物、抗血管内皮生长因子(vascular endothelial growth factor，VEGF)类药物、溶栓类药物和中药。本文将近年来有关RVO治疗药物的研究进展进行综述，希望对RVO的临床治疗提供参考。
[Key word]
[Abstract]
Retinalvein occlusion(RVO)is the most common retinal vascular disease. The main causes of visual impairment and blindness are macular edema and retinal neovascularization. Drug therapies are the effective and safe method in the treatment of RVO currently. The main drugs conclude corticosteroid drugs, anti-vascular endothelial growth factor drugs, thrombolytic drugs and traditional drugs. This article reviews the recent progress in RVO in order to provide some valuable references for clinical treatment.
[中图分类号]
[基金项目]
国家自然科学基金课题(No.81500724); 陕西省社会发展科技攻关项目(No.2016SF-063)
